Drug intelligence / Profile preview

delmopinol

Development stage
Unknown
Lead developer
Sinclair
Modality
Small Molecules
Administration
Oral
01

Overview

Delmopinol is a surface-active cationic agent used primarily as an oral rinse for the treatment of gingivitis and prevention of periodontitis. It acts by interacting with the early acquired pellicle—a thin layer of saliva polymers and proteins covering teeth and gums—forming a barrier that prevents microbial adhesion and colonization on tooth and gum surfaces. Delmopinol does not have significant bactericidal activity but disrupts plaque matrix, reduces viscosity of glucans, loosens cohesive properties of plaque, slows formation of salivary pellicle (the priming step for bacterial attachment), reduces adherence of pioneer bacteria to tooth/gingival surfaces, and impedes colonizing bacteria from adhering to the plaque matrix. It is less likely than chlorhexidine to cause staining. The drug has also been studied for its anti-inflammatory effects in the oral cavity[1][2][4][5].

Brand names
DecapinolPerioShieldDecapinol Oral Rinse
Other names
delmopinol hydrochloridedelmopinol HClDelmopinolum(+/-)-3-(4-propylheptyl)-4-morpholineethanol
02

Targets

Extracellular polymeric substance matrix of dental plaque (EPS matrix)

Beyond the preview

Go deeper on delmopinol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on delmopinol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call